Increasing requests from regulatory agencies have focused on evaluation of APIs and drug products during shipment. However, little guidance has been provided on how to address these concerns. This webinar will address these questions and explore approaches to assessing stability of biologic APIs and small molecule drug products throughout shipment.
Register free: www.pharmtech.com/pt/stability
Sponsored by Patheon
Introduction Drug formulation starts with the selection of various suitable excipients for the desired or required dosage forms. Drug-excipient interactions can...
This entry was posted in Analytical Discussion and tagged biorelevant, class 2, Dissolution media, glibenclamide, glyburide. The purpose of...
Abstract There are many techniques used to perform sample extraction for pharmaceutical solid oral dosage forms. Traditionally, agitation and...
ABOUT AUTHORS:U. A. Deokate, A. M. Gorde*Dept. Of Pharmaceutical Chemistry,Government College of Pharmacy, Hotel Vedant Road, Osmanpura,Aurangabad, Maharashtra, India...
Introduction Each year, 1.7 million people in the US are diagnosed with cancer; of these, approximately 580,000 will die...
The United States Pharmacopeia (USP) significantly changed the USP XXXI <61> Microbial Limits Test. The updated USP test is...
The development of analytical methods in the Quality by Design (QbD) framework is currently gaining great momentum in the...
© Interactive Pharm 2022
